Skip to main content

Advertisement

SpringerLink
Log in

The Degradation of Glycosaminoglycans by Intestinal Microflora Deteriorates Colitis in Mice

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

The biosynthesis and modification of mucopolysaccharides and glycosaminoglycans (GAGs), secreted from gastrointestinal mucosal cells, are increased in colitis and influence the viability of the defense barrier. Therefore, to evaluate the role of GAG-degrading intestinal microflora during the progression of colitis, we investigated the degradation activity of intestinal bacterial GAG, cytotoxicity of GAGs and their metabolites, such as iduronic acid, d-uronic acid or d-glucuronic acid and d-galactosamine or d-glucosamine, against intestinal cells. We also tested their deteriorative effects against colitis. Colitis was induced using 2,4,6-trinitrobenzene sulfonic acid (TNBS) with and without antibiotics in mice. The TNBS treatment caused colon shortening, increased myeloperoxidase activity, induced IL-1β, TNF-α, and IL-6 expression in the colon, activated NF-κB, and potentiated the GAG-degrading activities of intestinal microflora. The antibiotic treatment inhibited colon shortening, decreased myeloperoxidase activity, and reduced proinflammatory cytokine expression, NF-κB activation, and GAG degradation, induced by TNBS. Among the GAG metabolites, d-glucosamine and d-galactosamine showed cytotoxicity against intestinal cells, Caco-2 and IEC-18 cells, synergistically deteriorated the cytotoxicity of TNBS as well as the TNBS-induced colitis in mice. Based on these findings, intestinal microflora may degrade GAGs in colitis, their metabolites deteriorate the progress of colitis and antibiotics ameliorate the colitis by the inhibition of GAG-degrading bacterial growth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Benno, P., C. E. Leijonmarck, U. Monsen, and A. Uribe. 1993. Functional alterations of the microflora in patients with ulcerative colitis. Scand. J. Gastroenterol. 28:839–844. doi:10.3109/00365529309104019.

    Article  PubMed  CAS  Google Scholar 

  2. Gorbach, S. L., L. Nahas, A. G. Plaut, L. Weinstein, J. F. Patterson, and R. Levitan. 1968. Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy. Gastroenterology 54:575–587.

    PubMed  CAS  Google Scholar 

  3. Chung, K. T., G. E. Fulk, and M. W. Slein. 1975. Tryptophanase of fecal flora as a possible factor in the etiology of colon cancer. J. Natl. Cancer Inst. 54:1073–1078.

    PubMed  CAS  Google Scholar 

  4. Radema, S. A., S. J. van Deventer, and A. Cerami. 1991. Interleukin 1 beta is expressed predominantly by enterocytes in experimental colitis. Gastroenterology 100:1180–1186.

    PubMed  CAS  Google Scholar 

  5. Rafii, F., R. van Embdin, and L. M. C. van Lieshout. 1999. Changes in bacterial enzymes and PCR profiles of fecal bacteria from a patient with ulcerative colitis before and after antimicrobial treatments. Dig. Dis. Sci. 44:637–642. doi:10.1023/A:1026634229934.

    Article  PubMed  CAS  Google Scholar 

  6. Berrebi, D., J. Languepin, L. Ferkdadji, A. Foussat, P. De Lagausie, R. Paris, D. Emilie, J. F. Mougenot, J. P. Cezard, J. Navarro, and M. Peuchmaur. 2004. Cytokines, chemokine receptors, and homing molecule distribution in the rectum and stomach of pediatric patients with ulcerative colitis. J. Pediatr. Gastroenterol. Nutr. 37:300–308. doi:10.1097/00005176-200309000-00018.

    Google Scholar 

  7. Binder, V. 2004. Epidemiology of IBD during the twentieth century: an integrated view. Best Pract. Res. Clin. Gastroenterol. 18:463–479. doi:10.1016/j.bpg.2003.12.002.

    Article  PubMed  Google Scholar 

  8. Chandran, P., S. Satthaporn, A. Robins, and O. Eremin. 2003. Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (II). Surgeon 1:125–136.

    Article  PubMed  CAS  Google Scholar 

  9. Rath, H. C., M. Schultz, R. Freitag, L. A. Dieleman, F. Li, H. J. Linde, J. Scholmerich, and R. B. Sartor. 2001. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect. Immun. 69:2277–2285. doi:10.1128/IAI.69.4.2277-2285.2001.

    Article  PubMed  CAS  Google Scholar 

  10. Neurath, M., I. Fuss, and W. Strober. 2000. TNBS-colitis. Int. Rev. Immunol. 19:51–62. doi:10.3109/08830180009048389.

    Article  PubMed  CAS  Google Scholar 

  11. Hill, M. J., and B. S. Drasar. 1975. The normal colonic bacterial flora. Gut 16:318–323. doi:10.1136/gut.16.4.318.

    Article  PubMed  CAS  Google Scholar 

  12. Ganguly, N. K. , J. G. Kingham, B. Lloyd, R. S. Lloyd, C. P. Price, D. R. Triger, and R. Wright. 1978. Acid hydrolases in monocytes from patients with inflammatory bowel disease, chronic liver disease, and rheumatoid arthritis. Lancet 1(8073):1073–1075.

    Article  PubMed  CAS  Google Scholar 

  13. Rhodes, J. M., R. Gallimore, and E. Elias. 1985. Faecal mucus degrading glycosidases in ulcerative colitis and Crohn's disease. Gut 26:761–765. doi:10.1136/gut.26.8.761.

    Article  PubMed  CAS  Google Scholar 

  14. Rifkin, G. D., J. Silva Jr., and R. Fekety. 1978. Gastrointestinal and systemic toxicity of fecal extracts from hamsters with clindamycin-induced colitis. Gastroenterology 74:52–57.

    PubMed  CAS  Google Scholar 

  15. Wallace, J. L., W. K. Macnaughton, G. P. Morris, and P. L. Beck. 1989. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 96:29–36.

    PubMed  CAS  Google Scholar 

  16. Belmiro, C. L., H. S. Souza, C. C. Elia, M. T. Castelo-Branco, F. R. Silva, R. L. Machado, and M. S. Pavao. 2005. Biochemical and immunohistochemical analysis of glycosaminoglycans in inflamed and non-inflamed intestinal mucosa of patients with Crohn's disease. Int. J. Colorectal. Dis. 20:295–304. doi:10.1007/s00384-004-0677-2.

    Article  PubMed  Google Scholar 

  17. Gesner, B. M., and C. R. Jenkin. 1961. Production of heaprinase by bacteroides. J. Bacteriol. 81:595–604.

    PubMed  CAS  Google Scholar 

  18. Corfield, A. P., N. Myerscough, N. Bradfield, C. D. A. Corfield, M. Gough, J. R. Clamp, P. Durdey, B. F. Warren, D. C. C. Bartolo, K. R. King, and J. M. Williams. 1996. Colonic mucins in ulcerative colitis: evidence for loss of sulfation. Glycoconjugate J. 13:89–822. doi:10.1007/BF00702345.

    Article  Google Scholar 

  19. Greenberg, G. R. 2004. Antibiotics should be used as first-line therapy for Crohn’s disease. Inflamm. Bowel Dis. 10:318–320. doi:10.1097/00054725-200405000-00021.

    Article  PubMed  Google Scholar 

  20. Sartir, R. B. 2004. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126:1620–1633. doi:10.1053/j.gastro.2004.03.024.

    Article  Google Scholar 

  21. Mullane, K. M., R. Kraemer, and B. Smith. 1985. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J. Pharmacol. Methods 14:157–167. doi:10.1016/0160-5402(85)90029-4.

    Article  PubMed  CAS  Google Scholar 

  22. Choo, M. K., N. Kawasaki, P. Singhirunnusorn, K. Koizumi, S. Sato, S. Akira, I. Saiki, and H. Sakurai. 2006. Blockade of transforming growth factor-beta-activated kinase 1 activity enhances TRAIL-induced apoptosis through activation of a caspase cascade. Mol. Cancer Ther. 5:2970–2976. doi:10.1158/1535-7163.MCT-06-0379.

    Article  PubMed  CAS  Google Scholar 

  23. Lee, D. S., Y. S. Kim, C. N. Ko, K. H. Cho, H. S. Bae, K. S. Lee, J. J. Kim, E. K. Park, and D. H. Kim. 2002. Fecal metabolic activities of herbal components to bioactive compounds. Arch. Pharm. Res. 25:165–169. doi:10.1007/BF02976558.

    Article  PubMed  CAS  Google Scholar 

  24. Carmichael, J., W. G. DeGreff, A. F. Gazdar, J. D. Minna, and J. B. Mitchell. 1987. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res. 47:936–940.

    PubMed  CAS  Google Scholar 

  25. Keighley, M. R., and Y. Arabi. 1978. Influence of inflammatory bowel disease on intestinal microflora. Gut 19:1099–1104. doi:10.1136/gut.19.12.1099.

    Article  PubMed  CAS  Google Scholar 

  26. Onderdonk, A. B., J. A. Aermos, and J. G. Barblett. 1979. The role of the intestinal microflora in experimental colitis. Am. J. Clin. Nutr. 30:1819–1825.

    Google Scholar 

  27. Appleton, I., A. Tomlinsom, and D. A. Willoughby. 1996. Induction of cyclo-oxygenase and nitric oxide synthase in inflammation. Adv. Pharmacol. 35:27–78. doi:10.1016/S1054-3589(08)60274-4.

    Article  PubMed  CAS  Google Scholar 

  28. Sartor, R. B. 1994. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 106:533–539.

    PubMed  CAS  Google Scholar 

  29. Singer, I. I., D. W. Kawka, S. Schloemann, R. Tessner, T. Riehl, and W. F. Stenson. 1998. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115:297–306. doi:10.1016/S0016-5085(98)70196-9.

    Article  PubMed  CAS  Google Scholar 

  30. Gesner, B. M., and C. R. Jenkin. 1961. Production of heparinase by Bacteroides. J. Bacteriol. 81:595–604.

    PubMed  CAS  Google Scholar 

  31. Salyers, A. A., J. R. Vercellotti, S. H. E. West, and T. D. Wilkins. 1977. Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon. Appl. Environ. Microbiol. 34:319–322.

    Google Scholar 

  32. Hong, S. W., B. T. Kim, H. Y. Shin, W. S. Kim, K. S. Lee, Y. S. Kim, and D. H. Kim. 2002. Purification and characterization of novel chondroitin ABC and AC lyases from Bacteroides stercoris HJ-15, a human intestinal anaerobic bacterium. Eur. J. Biochem. 269:2934–2940.

    Article  PubMed  CAS  Google Scholar 

  33. Salyers, A. A., M. Pajeau, and R. E. McCarthy. 1988. Importance of mucopolysaccharides as substrates for Bacteroides thetaiotaomicron growing in intestinal tracts of exgermfree mice. Appl. Environ. Microbiol. 54:1970–1976.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Life and Nanopharmaceutical Sciences, Kyung Hee University, 1, Hoegi, Dongdaemun-Ku, Seoul, 130-701, South Korea

    Hye-Sung Lee, Kwon-Yeul Ryu & Dong-Hyun Kim

  2. Department of Pharmaceutical Science, Kyung Hee University, 1, Hoegi, Dongdaemun-Ku, Seoul, 130-701, South Korea

    Song-Yi Han & Dong-Hyun Kim

Authors
  1. Hye-Sung Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Song-Yi Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kwon-Yeul Ryu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dong-Hyun Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dong-Hyun Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, HS., Han, SY., Ryu, KY. et al. The Degradation of Glycosaminoglycans by Intestinal Microflora Deteriorates Colitis in Mice. Inflammation 32, 27–36 (2009). https://doi.org/10.1007/s10753-008-9099-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-008-9099-6

KEY WORDS

Search

Navigation